blog about Mlabs Introduces Realtime PCR for Faster Tuberculosis Detection

Tuberculosis (TB), caused by Mycobacterium tuberculosis complex (MTBC), remains one of humanity's most persistent public health challenges. While treatment has advanced significantly in the antibiotic era, timely and accurate diagnosis—particularly in resource-limited settings—continues to be a critical barrier to effective disease control.

Traditional TB diagnostic methods face significant limitations:

• Bacterial culture: While considered the gold standard, requires 2-8 weeks for results—an unacceptable delay for rapidly progressing cases.
• Sputum smear microscopy: Rapid but insensitive, detecting only cases with ≥10,000 bacteria/mL.
• Tuberculin skin tests/IGRAs: Detect infection but cannot distinguish active from latent disease.

MLabs' real-time PCR DNA test addresses these challenges through:

• Speed: Results in 2-4 days versus weeks for culture
• Sensitivity: Detects as few as 10-100 DNA copies/reaction
• Specificity: Precisely targets MTBC-specific sequences
• Quantification: Provides estimated bacterial load

The test utilizes:

1. Specific primers/probes targeting conserved MTBC sequences
2. Real-time fluorescence monitoring during PCR amplification
3. Threshold cycle (Ct) values to estimate initial DNA quantity

The assay identifies all major MTBC members:

• M. tuberculosis (primary human pathogen)
• M. bovis (including BCG vaccine strain)
• M. africanum (West African strains)
• M. microti (rodent-adapted strains)
• Other rare MTBC variants

Note: While detecting all MTBC members, the test cannot differentiate between specific species within the complex.

The test serves multiple diagnostic roles:

• Rapid screening of suspected TB cases
• Respiratory specimen testing (sputum, BAL, bronchial washings)
• Tissue sample analysis (fresh or FFPE)
• Complementary use with culture (for speciation and DST)

Positive results indicate MTBC DNA detection but require clinical correlation. Negative results don't fully exclude TB due to potential:

• Low bacterial loads
• Sampling issues
• PCR inhibitors

The test can detect katG gene mutations associated with isoniazid resistance, though:

• Absence of mutations doesn't guarantee sensitivity
• Other resistance mechanisms exist
• Culture-based DST remains definitive

For optimal results:

• Respiratory samples: ≥1 mL in sterile container
• Tissue samples: ≥5 mm fresh or FFPE
• Transport: Refrigerated (2-8°C) within 7 days

• Testing available daily (including weekends)
• Turnaround: 2-4 business days
• CPT code: 87556

This molecular advancement represents a significant leap forward in TB diagnostics, enabling earlier detection and treatment initiation while complementing traditional methods for comprehensive patient management.